When is it a good idea to use medications that lower uric acid levels to treat gout?

Photo of a man at a doctor's appointment

Some people are able to manage their gout by changing their diet and cutting back on alcohol. Others need to take medication to reduce their uric acid levels over the long term. Long-term treatment with this type of medicine is especially suitable for frequent gout attacks and complications such as kidney stones.

Gout is caused by high uric acid levels. If uric acid levels in the blood are too high, uric acid crystals may start to form in the joints and trigger painful gout attacks. Having high uric acid levels for years may lead to complications and damage the joints.

Sometimes there is just a single gout attack, but it is possible that the attacks will keep coming back. Whether and when treatment with medications that lower uric acid levels should be started will depend on various factors – like the severity and frequency of the attacks.

These medications need to be taken over a period of several years and may have side effects or interact with other kinds of medicine. So it's a good idea to carefully weigh the pros and cons of the treatment together with your doctor.

When are medications that lower uric acid levels used?

Treatment with medication is commonly recommended in the following situations:

  • At least one severe gout attack has occurred.
  • There have been repeated gout attacks.
  • Uric acid deposits in the soft tissue called tophi have developed.
  • There is already some joint damage.

Another reason for starting medication may be that changes to your diet alone are not enough to lower uric acid levels, or that the levels are very high.

Some people experience no further problems – or only rarely – for years after the first gout attack. That is why experts recommend considering getting fast treatment with medications that can lower uric acid levels only if the first attack was very severe.

In addition to the number and severity of the gout attacks, how well you tolerate the medication is also an important factor. Some people also find it unpleasant to have to take pills every day, while others may be more concerned about the long-term effects of gout and find peace of mind in taking medication.

What medications can be used?

The drugs allopurinol or febuxostat are commonly used to lower uric acid levels. They restrict the breakdown of purines, reducing the uric acid levels. The medications are taken after a meal with plenty of fluids.

It is recommended that you start the treatment at a low dose and then gradually increase it. Taking allopurinol as an example: For people with mild gout a dose of 200 to 300 mg allopurinol per day is usually enough, while 400 to 500 mg per day can be required to treat severe gout. The maximum dose of allopurinol is 800 mg per day, but that is only rarely needed.

After the treatment has been started, doctors will first check how high your uric acid levels are and how the symptoms are doing every three months. Less frequent check-ups, for example once a year, are enough at a later stage.

Medications such as probenecide and benzbromarone from the uricosuric group are another option. They work by increasing the amount of uric acid expelled by the kidneys. They can be taken in addition to allopurinol, but are only prescribed very rarely.

How effective are the medications?

Allopurinol and febuxostat are very effective at reducing uric acid levels. Most experts believe that taking these medications can successfully prevent complications of gout. Although only a few studies have looked into long-term use so far. they suggest that the medications reduce the risk of gout attacks. So it's not possible to say exactly what people with gout can expect from long-term treatment with these medications – for instance, how many gout attacks can be avoided or how well the treatments can prevent joint damage.

What should be considered when taking the medication?

Especially during the first few months of treatment, medications that lower uric acid levels may even increase the risk of gout attacks. The reason for this is that any uric acid crystals already present only break down gradually. When this happens, small particles of the crystals may be washed into the joint, where they then cause an inflammation that leads to a gout attack. That happens quite often. It is thought that it can take up to two years for the body to get rid of all uric acid crystals.

To prevent gout attacks during this time, low-dose colchicine or a non-steroidal (NSAID) is often also prescribed for the first three to six months. That effectively reduces the risk of those kinds of attacks. But even if one occurs, it's not necessary to stop taking the medication that lowers the uric acid levels.

What are the possible side effects?

Rashes are a possible side effect of allopurinol. That happens to about one out of 100 people. Most of these rashes are mild and don't have any serious consequences. But in rare cases, a rash may be a sign of a hypersensitive reaction to allopurinol That can lead to serious complications. People who have chronic kidney disease are especially at risk. So if they suddenly feel ill, develop a fever, cold-like symptoms or a rash, it's important to seek medical attention quickly.

The possible side effects of febuxostat include nausea and joint pain. Rashes and serious hypersensitivity reactions are also possible during treatment with febuxostat.

And it is believed that febuxostat could increase the risk of cardiovascular disease. The studies do not reach clear conclusions, though. So people with cardiovascular disease are still advised to take allopurinol rather than febuxostat.

Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie (DGRh). S3-Leitlinie Diagnostik und Therapie der Gicht. AWMF register no.: 060-005. 2024.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Evidence search for the S3 guideline on diagnosis and treatment of gout: Drug treatment of a gout attack: Allopurinol versus febuxostat. Commission V22-06d. 2023

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Evidence search for the S3 guideline on diagnosis and treatment of gout: Drug treatment of a gout attack: Xanthine oxidase inhibitors. Commission V22-06c. 2023

National Institute for Health and Care Excellence (NICE). Gout: diagnosis and management (NICE Guidelines; No. 219). 2022.

Qaseem A, Harris RP, Forciea MA. Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2017; 166(1): 58-68.

Rote Liste. Fachinfo.de (Febuxostat). 2022.

Zhang F, Wang Y. The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis. Jt Dis Relat Surg 2025; 36(3): 562-576.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?”

Über diese Seite

Updated on November 17, 2026

Next planned update: 2029

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

Stay informed

Subscribe to our newsletter or newsfeed. You can find our growing collection of films on YouTube.